School of Medicine
Showing 301-400 of 418 Results
-
Cristin Runfola
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Runfola's research focuses on the epidemiology of dysregulated eating and weight concerns in undeserved populations and her primary interest is in developing and testing the efficacy of clinical interventions designed to improve outcome for eating disorders.
With support from GFED, Dr. Runfola adapted the Uniting Couples in the treatment of Anorexia Nervosa (UCAN) therapy manual for couples in which one or both members have binge-eating disorder (UNITE) and recently completed pilot testing on this treatment. She is in the process of expanding this treatment for all couples affected by binge eating, and is submitting a grant to fund future work testing efficacy. -
Samuel Ricardo Saenz
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Sam Saenz was born in the Bay Area and received his bachelor’s degree in psychology from Stanford University. He completed his medical degree at UC Irvine’s Program in Medical Education for the Latino Community, and he also obtained a Master’s in Public Health from UC Berkeley. After serving as chief psychiatry resident during his psychiatry residency at Stanford, he completed a fellowship in public psychiatry at UC San Francisco. His professional interests include fostering the next generation of diverse mental health providers as well as advancing justice, equity, and inclusion (JEDI) work in academic medicine.
-
Debra Safer
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsPrimary research interests include the nature and treatment of eating disorders
(particularly bulimia nervosa and binge eating disorder), the development and treatment of obesity, and the development and treatment of problematic eating patterns in patients following bariatric surgery. -
Gregory Lee Sahlem
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioDr.Sahlem is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences. He is board-certified in general psychiatry and addictions medicine, as well as fellowship-trained in the research and clinical application of neuromodulation-based treatments including repetitive Transcranial Magnetic Stimulation (rTMS), electroconvulsive therapy (ECT), and vagus nerve stimulation (VNS). He additionally has advanced training in the treatment of mood and sleep disorders. In addition to being an active clinician, Dr.Sahlem is a member of the Stanford Brain Stimulation Lab and directs the Addictions Research Section of the Lab.
Major areas of study for Dr.Sahlem include: The development of rTMS as a focused treatment for addictive disorders; the development of a novel form of ECT theorized to have reduced cognitive side effects, Focal Electrically Administered Seizure Therapy (FEAST), and; the further development of rTMS for the treatment of mood disorders. -
Khalid Salaheldin, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKhalid Salaheldin, MD, holds the position of Clinical Assistant Professor and serves as an interventional psychiatrist within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. His expertise lies in the specialized care of individuals who present with early psychosis.
At Stanford, Dr. Salaheldin's current responsibilities encompass a range of clinical activities, including evaluating patients with early psychosis at the INSPIRE clinic, providing care in the inpatient psychiatric unit, and delivering interventional psychiatry services. In addition to his clinical work, he is actively engaged in teaching, conducting research, and fostering collaborative learning among his patients and colleagues.
His treatment philosophy is a recovery oriented and compassionate approach evaluating vital underlying factors alongside pharmacotherapy & neuromodulatory interventions including: sleep, exercise, nutrition, mindfulness, therapy integration, underlying medical issues, substance use, psychosocial history, and importantly patients’ current relationships (including pets of course!). His approach focuses on meeting patients where they are at in their health journey, aligning treatment with their personal goals, and being actively present in their management.
Dr. Salaheldin’s research interests include early psychosis interventions, underlying medical causes of psychiatric symptoms, neuromodulation, community/global mental health, spirituality and mental health, healthcare worker mental health, novel psychiatric therapeutics, and mental health parity & policy.
Before joining Stanford, Dr. Salaheldin served as the academic chief resident at Northwell Health, where his focus centered on designing a consult liaison service for patients experiencing a first episode of psychosis. This pioneering initiative aimed to provide compassionate support to patients and their families from the moment they arrived at the emergency room, throughout their inpatient stay, and during their transition to the outpatient setting. He hopes to continue this work on a local and global scale.
“True compassion means not only feeling another's pain, but also being moved to help relieve it. ” —Daniel Goleman -
Katherine Sanborn
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr Katherine Sanborn specializes in the treatment of psychiatric inpatients. She has practiced Psychiatry for more than 15 years. Dr. Sanborn has a special interests in residency education, psychotherapy training, administration and developmental psychopathology.
-
Maureen Satyshur
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Satyshur is a licensed clinical psychologist who specializes in Acceptance and Commitment Therapy, Dialectical Behavioral Therapy, as well as interventions for LGBTQ+ individuals.
-
Parnika Prashasti Saxena
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.
-
Alan F. Schatzberg
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.
-
Mariana Schmajuk
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Clinical Assistant Professor, Psychiatry and Behavioral SciencesBioMariana Schmajuk received her medical school education at Boston University School of Medicine in 2012. She completed her General Adult Psychiatry Residency program Mount Sinai School of Medicine in New York in 2016, serving as Chief Resident with a focus on the early transition from medical school to residency. She went on to complete her Consult-Liaison fellowship at New York-Presbyterian Hospital Columbia University Medical Center in 2017.
Dr. Schmajuk joined Stanford University CLP team in 2017. She is a primary member of the emergency medicine consultations, working collaboratively with a nurse practioner, social worker and residents. Clinically, Dr. Schmajuk focuses on treating patients with terminal neurological disorders and oncological processes. Dr. Schmajuk is the director of the Psychosomatic Continuity clinic where residents and fellows are able to assess and longitudinally treat patients with psychiatric sequela in the context of complex medical illness. She has a particular interest in brief psychotherapeutic interventions. She enjoys teaching medical students about CL psychiatry and interviewing skills. At present, Dr. Schmajuk is using techniques of applied improvisation to educate psychiatry residents and others about the building blocks of communication. She also is an active member of the bioethics committee. -
Shebani Sethi MD, ABOM
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsImproving metabolic and mental health through dietary metabolic therapies, pharmacological optimization, and other lifestyle interventions in those with severe mental illness, such as bipolar disorder, schizophrenia, major depression is a major focus of her research. Clinical and academic interests include management of psychiatric disorders with co-morbid obesity, insulin resistance, metabolic dysfunction and/or eating disorders, particularly binge eating disorder and bulimia nervosa.
-
Ripal Shah
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioRipal Shah, M.D., M.P.H. is a Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences. She specializes clinically in reproductive psychiatry (the Women's Wellness Clinic - pre-conception, pregnancy, postpartum, breastfeeding, fertility, pre-menstrual dysphoric disorder (PMDD), reproductive and sexual health disorders), lifestyle and integrative approaches to health (the Stanford Center for Integrative Medicine - vitamins, supplements, exercise, behavioral modifications, hypnosis), and in physician wellness (the WellConnect program - serving Stanford resident/fellow/faculty physicians). Dr. Shah is regarded as one of the world's experts in PMDD, and one of very few specifically studying PMDD in women of color.
Her research areas of focus are on women's reproductive psychiatry, integrative approaches to mental health, diversity & inclusion program development, ethnicity-dependent variability in mental health access and treatment response, psychedelics, spirituality, and minority stress. Her lab also studies the role of Eastern religions on mental health in the U.S., and the connection between Hinduism and psychedelics. Outside of consultations, she specializes in psychotherapy for minority populations, particularly those struggling with issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation), as well as cognitive-behavioral therapy for ADHD and anxiety disorders. She has received specialized training in working with Black and South Asian populations.
While in training at Stanford, she served as Chief Resident and led community partnerships and DEI efforts. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, volunteering after wildfires, hurricanes, and earthquakes. She founded and led the Diversity & Inclusion Advisory Council (DIAC) for psychiatry faculty and residents which is now a model organization for programs across the country, built and then graduated from a Diversity & Health Equity track in the residency, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership. Before her time at Stanford, she completed an M.P.H. at Harvard University in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York with tuition merit scholarship, and a B.S. from Duke University in Economics and Biochemistry.
She is board certified in Adult Psychiatry, Addiction Medicine, and Obesity Medicine, and board-eligible in Integrative Medicine. She pursued additional training in the fields of Emergency Medicine and Internal Medicine, which has informed her evidence-based approach to integrative medicine. She is credentialed as one of very few physicians in the country able to bill for TMS (transcranial magnetic stimulation), ECT (electroconvulsive therapy), hypnosis, and ketamine infusions. She completed a Certificate in Psychedelic-Assisted Therapies and Research, with training from the Multidisciplinary Association for Psychedelic Studies (MAPS), and also completed MAPS' program MDMA Assisted Therapy Researcher Training. She is on the MDMA Clinical/Monitoring Team for Stanford's Pilot Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: (MDMA+CBT-4-OCD). She advises several companies and research teams on the clinical use of psychedelics in psychiatry, and often consults with media and tech companies as an industry expert. She has been seen in TIME, Forbes, and the Washington Post, and in 2020 was awarded one of the top 25 rising stars in medicine by Medscape. -
David Smith, M.D.
Adjunct Professor, Psych/General Psychiatry and Psychology (Adult)
BioDr. Smith is a psychiatrist and clinical psychopharmacologist in private practice in Palo Alto, CA, and an Adjunct Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He majored in both biological science and English literature at Cornell University, received his M.D. from UCLA, and completed his psychiatry residency and NIMH research fellowship at Stanford University School of Medicine and Hospital.
-
Natalie Solomon
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Solomon is a licensed psychologist, board certified in behavioral sleep medicine, and a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Solomon conducts research as a member of the Computational Psychiatry, Neuroimaging, Sleep Lab (CoPsyN Sleep Lab) and treats patients in the Sleep Health and Insomnia Program (SHIP). Dr. Solomon specializes in the study and treatment of sleep disorders. Her clinical interests include the intersection of sleep difficulties with overall quality of life and women’s health. Dr. Solomon enjoys treating a variety of sleep difficulties, including insomnia, hypnotic dependence, circadian rhythm disturbances, NREM parasomnias, and nightmares. Dr. Solomon additionally consults, teaches undergrads, graduate students, and continuing studies, supervises postdoctoral fellows, and trains providers to deliver insomnia treatment.
-
Hugh Brent Solvason PhD MD
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsMy work is focused on novel interventional treatment approaches for treatment resistant unipolar and bipolar depression. We are currently enrolling patients with treatment refractory bipolar depression for a radiosurgical neuromodulation study. We are awaiting the start of enrollment for a DBS in unipolar depression study.
I am also working with children in Sub Saharan Africa. Primarily I am focused on methods to assess well-being, and long term outcomes for these vulnerable children. -
Barbara Sommer
Associate Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsI am interested in the clinical investigation of cognitive stresses during younger adulthood that may give rise to frank intellectual impairment with older age. Examples may include specific kinds of chronically taken medications.
-
Maria-Christina Stewart
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Stewart specializes in the prevention and treatment of eating, obsessive-compulsive, anxiety, and depressive disorders - and the intersection between them. At Stanford she lectures on evidence-based eating disorder treatments for children and adolescents. Dr. Stewart also runs a private practice, writes, consults, lectures, and hosts the 'Meaning Vs Merit' podcast - exploring how to find meaning in our achievement and merit-focused culture.
-
Steven Tate
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Steven Tate serves as a Clinical Assistant Professor specializing in addiction medicine within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He earned his medical degree from the University of Chicago and completed his internal medicine residency at the University of Pennsylvania. He then successfully completed a fellowship in addiction medicine at Stanford. With a Master's in medical statistics from the London School of Hygiene & Tropical Medicine, Dr. Tate brings a rigorous and evidence-based approach to his work.
Dr. Tate sees patients in the Stanford Dual Diagnosis Clinic, providing comprehensive care for individuals with co-occurring mental health and substance use disorders. He also attends on the inpatient addiction medicine consult service, where he offers guidance to healthcare professionals on complex addiction-related cases. Driven by his dedication to improving care for patients with substance use disorders, he focuses his work on educating future addiction professionals and translating evidence into practice. -
Allison L. Thompson, Ph.D.
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Allison Thompson specializes in the treatment of Post-Traumatic Stress Disorder, anxiety and depression, and severe mental illness. She has practiced at Stanford since 2008. She has a special interest in the treatment of underrepresented and underserved populations, such as people of color.
-
Aubrey Toole, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Aubrey Toole is a licensed psychologist whose research and clinical work has focused on the treatment and prevention of eating and body image problems and the potential benefits of compassion- and acceptance-based interventions. Dr. Toole further specializes in treating eating and body image concerns in high performance athletes at Stanford. Clinically, she works with a range of presentations, including eating and body image concerns, mood and anxiety difficulties, interpersonal problems, and post-traumatic stress, as well as rigid perfectionism, harsh self-critical thinking, and shame. She completed her bachelor’s degree in Psychology with Highest Honors at UC Berkeley and her Ph.D. in Clinical Psychology at Emory University. She completed her predoctoral internship at the Emory University School of Medicine Department of Psychiatry, where she worked with children, adolescents, and young adults with eating disorders, emotion regulation difficulties, anxiety, depression, OCD, and PTSD. She completed her postdoctoral fellowship at Stanford University’s School of Medicine within the Psychosocial Treatment Clinic, where her training focused on evidence-based treatments for eating disorders, anxiety and mood disorders, couples, and high-performance athletes, as well as clinical supervision.
-
Mickey Trockel
Professor of Psychiatry and Behavioral Sciences
BioMickey Trockel is the Director of Evidence Based Innovation for the Stanford University School of Medicine WellMD Center. His development of novel measurement tools has led to growing focus on professional fulfillment as a foundational aim of efforts to promote physician well-being. His scholarship also identifies interpersonal interactions at work as a modifiable core determinate of an organizational culture that cultivates wellness.
Dr. Trockel serves as the chair of the Physician Wellness Academic Consortium Scientific Board, which is a group of academic medical centers working together to improve physician wellbeing. The consortium sites have adopted the physician wellness assessment system Dr. Trockel and his colleagues have developed, which offers longitudinal data for benchmarking and natural experiment based program evaluation. His previous research included focus on college student health, and evaluation of the efficacy of a national evidence based psychotherapy dissemination effort. His more recent scholarship has focused on physician wellbeing. He is particularly interested in developing and demonstrating the efficacy of interventions designed to promote wellbeing by improving social culture determinants of wellbeing across student groups, employee work teams, or larger organizations. -
Yuri Tsutsumi
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsClinical Psychology
-
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone MD, PhD is an Assistant Professor with Stanford School of Medicine’s Department of Psychiatry and Behavioral Sciences. He works collaboratively in the department’s Neuropsychiatry clinic and his clinical focus includes treating patients with diverse and complex presentations at the interface of psychiatry and neurology with particular interest in functional neurological disorders. He sees a small cohort of psychotherapy patients in Individual Psychotherapy Clinic. He also works weekend shifts on Stanford’s inpatient psychiatry units.
As a neuroscientist, he is interested in preclinical models of mental illness and investigating new therapies for mood disorders and addiction. In particular, he is interested in defining new cell types and evolutionary conserved circuits in emotional processing centers of the brain with the hope of finding new entry points for novel therapeutics. Currently under the mentorship Dr Robert Malenka, he is using optogenetic, chemogenetic, neuroimaging and behavioral approaches in mouse models of addiction to uncover vulnerable brain circuitry in opioid use disorder. Under the mentorship of Dr Alan Schatzberg he is investigating the efficacy of buprenorphine augmentation to IV ketamine infusion at reducing suicidality in treatment resistant depression.
Prior to training in psychiatry at Stanford’s research residency track Jason received his bachelor’s degree in biology and philosophy from Union College. He spent three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke investigating and developing MRI reportable contrast agents to map neuronal connectivity. Following this he entered the Medical Scientist Training Program (MD/PhD) at the State University of NY Stony Brook University. There he completed a doctoral dissertation in neuroscience under the mentorship Dr. Josh Huang at Cold Spring Harbor Laboratory. His thesis work employed mouse genetic dissections of excitatory and inhibitory cortical circuits with a focus on the circuitry of chandelier inhibitory interneurons in prefrontal cortex.
In addition to his research and clinical work, Jason is passionate about teaching, mentorship, and resident clinical supervision. He joined a working group early in his clinical residency to restructure trainee’s neuroscience education. He teaches introductory lectures in the neuroscience of addiction, PTSD, psychosis, and mood disorders. He also leads resident group supervision in their introductory psychodynamic psychotherapy clinical experience. He supervises medical students, residents, and clinical fellows in Neuropsychiatry clinic. Finally, to contribute to the Stanford clinical community, he leads a support group for Internal Medicine interns and residents. -
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Peter Johannes van Roessel
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy (TFP) via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and contributes to and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive ‘awareness’ (insight) in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Daniel Virtheim
Clinical Research Coordinator, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator
-
Lynn C. Waelde, Ph.D.
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioLynn C. Waelde, Ph.D. is an Adjunct Clinical Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and Professor Emeritus in the Psychology Department at Palo Alto University. Dr. Waelde’s many collaborative publications address the impacts of traumatic events and ways to use mindfulness and meditation to promote resilience and recovery from stress and trauma. She founded and directed the Inner Resources Center which offered intervention groups and trainings to thousands of participants, clients, and therapists over the past 15 years. Dr. Waelde is the author of Mindfulness and Meditation in Trauma Treatment: The Inner Resources for Stress Program, published in 2022. She has taken a special interest in family caregivers and the Inner Resources for Stress program has been named a Best Practice by the Benjamin Rose Institute on Aging. She recently coauthored Family Caregiver Distress, which is forthcoming in 2023. She is on the editorial board of Journal of Traumatic Stress and an Associate Editor of Mindfulness.
-
Diane Elizabeth Wakeham
Clinical Research Coordinator Associate, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator Associate, INSPIRE Clinic, Psychiatry and Behavioral Sciences
-
Po Wang
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBipolar Disorders, Psychopharmacology, Treatment, Anticonvulsants, Mood stabilizers
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Julia Weinman
Doctoral Research Affiliate, Psych/General Psychiatry and Psychology (Adult)
BioJulia Weinman, MS, MA is a doctoral research affiliate within the Department of Psychiatry and Psychology at the Stanford School of Medicine in the Neuropsychology, Mood and Anxiety Disorder, and Women's Mental Health Lab. She is a doctoral candidate, pursuing her PhD in clinical psychology at Palo Alto University. Her research focuses on interpersonal trauma, empowerment, and post-traumatic growth. Currently, she is working with Dr. Jennifer Keller on the Building Empowerment and Resilience (BEAR) program for adult women with histories of interpersonal trauma.
